| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.7M | +19.8% |
| Cost of Revenue | $2.0M | -4.0% |
| R&D Expense | $16.5M | -11.0% |
| SG&A Expense | $16.3M | -1.5% |
| Operating Income | -$30.8M | +10.1% |
| Interest Expense | $231K | -96.4% |
| Pre-tax Income | -$39.3M | +6.3% |
| Income Tax | $0 | — |
| Net Income | -$38.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.0M | +23.7% |
| Accounts Receivable | $1.5M | -22.4% |
| Inventory | $10.3M | +12.6% |
| Current Assets | $32.2M | +15.1% |
| Total Assets | $53.4M | +5.2% |
| Current Liabilities | $19.7M | +40.9% |
| Total Liabilities | $44.4M | -3.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.4M | +11.6% |
| Capital Expenditures | $16K | — |
| Investing Cash Flow | -$231K | — |
| Financing Cash Flow | $31.2M | -8.8% |
| Free Cash Flow | -$29.4M | — |
| +6.8% |
| EPS (Basic) | -$130.69 | -7201.1% |
| EPS (Diluted) | -$130.69 | -7201.1% |
| Stockholders' Equity |
| $6.5M |
| +32.6% |